IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-05-08 (sphericalinsights.com)
Global virtual clinical trials market size, analysis
Global virtual clinical trials The size of the market is planned USD 15.55 billion here 2033, to a 5.98% TCAC and the corporate covance key, IQVIA.
Read more
2025-05-08 (appliedclinicaltrialsonline.com)
Impact of FDA Project FrontRunner on Oncology Drug Development - 1695580
This event is now available on demand.
Read more
2025-05-07 (healthtalk.no)
DMP and new methods: New measures cut time for case processing - industry pulls out the time
New measures reduce the processing time, but the industry still delays the process, says DMP and new methods.
Read more
2025-05-07 (immedicohospitalario.es)
A report confirms that Spain finances the 71 of drugs approved by EMA |
A report prepared by the IQVIA for EFPIA has revealed this data that shows the improvement in patients access to new medications in Spain, however, from Pharmaindustria they value that a regulatory framework is still necessary with the ability to encourage ...
Read more
2025-05-07 (imfarmacias.es)
Spanish pharmacies serve an average of 789 people per week |
IQVIA data published in the Drug Observatory have revealed some data on pharmacies in 2024 according to the average the purchase value was 30 euros and among these a 61 correspond to prescription medications and a 31 ...
Read more
2025-05-07 (diariofarma.com)
Wait 2024: Spain improves in almost all indicators, to the EU's countercurrent | @
The Wait 2024 report confirms a positive evolution in access to medicines in Spain, with more financed products and a reduction of the times, in contrast to the generalized stagnation observed in Europe.
Read more
2025-05-07 (vereniginginnovatievegeneesmiddelen.nl)
In the Netherlands, patients have to wait even longer for new medicines - Association of Innovative Medicines
The waiting time for patients to access innovative medicines has increased again in the Netherlands: to an average of 459 days.
Read more
2025-05-07 (pharmvestnik.ru)
The costs of medicines in the United States increased by 11.4% in 2024 »Pharmacious tire
In 2024, the costs of drugs in the United States reached a record $ 487 billion. This is 11.4% more compared to a year earlier, the IQVIA research company reports.
Read more
2025-05-07 (smartkarma.com)
IQVIA Holdings Inc.'s stock price soars to $153.30, marking an impressive +4.86% increase |
IQVIA Holdings Inc. (IQV) 153.30 USD +7.10 (+4.86%) Volume: 2.88M IQVIA Holdings Inc.'s stock price soared to 153.30 USD, marking a significant session uptick of +4.86% with a trading volume...
Read more
2025-05-07 (newstrail.com)
Digital Health Revolution Fuels Growth in Patient Engagement Solution Market -
Patient Engagement Solutions Market Overview
Read more
2025-05-07 (biospace.com)
Ironwood Pharmaceuticals Reports First Quarter 2025 Results -
– On track to achieve FY 2025 financial guidance; raised adjusted EBITDA guidance to greater than $105 million for 2025 –
Read more
2025-05-06 (investing.com)
Iqvia holdings exceeds LPA forecast in the 1st TRI, 2025, actions fall by Investing.com
Iqvia holdings exceeds LPA forecast in the 1st TRI, 2025, CAEM actions
Read more